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Background: The purpose of this study was to compare the efficacy of self-retaining stent 
(SRS) bicanalicular intubation with bicanalicular silicone (Crawford) intubation in patients with 
canalicular and punctal obstruction.
Methods: In this prospective, randomized clinical trial, 38 patients with canalicular or punctal 
obstruction (25 partial, 13 complete) and epiphora were randomized into two groups. Twenty-one 
patients (14 with partial and seven with complete obstruction) underwent SRS intubation and 
17 patients underwent bicanalicular silicon intubation in a randomized fashion.
Results: After a mean follow-up of 6 months following tube removal, 16 (76%, 12 partial, four 
complete) of the 21 eyes in the SRS intubation group and 13 (76%, 10 partial, three complete) 
in the bicanalicular silicon intubation group had a successful outcome and remained symptom-
free. For partial obstructions, the success rate was 85% and 90% for the SRS and bicanalicular 
silicon intubation groups, respectively. The corresponding values for complete obstruction were 
63% and 50% for the SRS and bicanalicular silicon intubation groups, respectively.
Conclusion: SRS could effectively substitute for a more extensive procedure such as bicanali-
cular silicon intubation in patients with canalicular obstruction, particularly those with partial 
obstruction. The newly developed SRS intubation procedure has the advantages of simple, 
easy implementation and extubation, low cost, and a lower rate of trauma when compared with 
bicanalicular silicon intubation.
Keywords: self-retaining bicanalicular intubation, Crawford intubation, canalicular 
obstruction
Introduction
Punctal or canalicular stenosis is a frequent cause of epiphora resulting from various 
etiologies, such as chronic blepharitis and conjunctivitis, eyelid malposition, trauma, 
adverse effects of topical or systemic medications, and neoplasm involving the eyelid. 
An increased incidence of punctal and canalicular stenosis has been noted in patients 
receiving systemic chemotherapy, such as docetaxel or 5-fluorouracil.1–3 Patients often 
present with complaints of tearing and epiphora due to insufficient drainage. The 
condition can be seen in any age group.
The classical management of canalicular stenosis is identification of the causative 
agent and, if possible, its cessation, but often this is not possible. Patients with symptom-
atic canalicular stenosis should undergo timely insertion of a bicanalicular silicon stent to 





canalicular intubation for patients with canalicular obstruction. 
In patients with nasolacrimal duct and canalicular obstruc-
tion, preferred procedures include dacryocystorhinostomy 
with bicanalicular intubation or monocanalicular intubation. 
However, in patients with canalicular obstruction without 
nasolacrimal duct obstruction, some prefer to use Goldberg 
cerclage or bicanalicular silicon intubation. Recently, a new 
design has been developed known as the self-retaining stent 
(SRS, FCI Ophthalmics, Issy-Les Moulineaux, France) for 
patients with punctal or canalicular stenosis or obstruction. 
In this study, we compared the efficacy and safety of SRS 
intubation with that of bicanalicular silicone (Crawford)   
intubation in patients with canalicular obstruction.
Materials and methods
In this prospective comparative interventional case series, 
38 eyes from 38 consecutive patients with punctal or canali-
cular stenosis or obstruction were included. Punctal stenosis 
was detected on slit-lamp examination and diagnostic probing. 
Diagnosis of canalicular stenosis or obstruction was made on 
the basis of a diagnostic probing test. If complete obstruc-
tion was detected, patients were only included if they had 
membranous canalicular obstruction, so that the probe could 
be forwarded after a click sensation and pass the membrane 
within the canaliculi. The patients underwent SRS insertion 
under local anesthesia or bicanalicular silicon intubation under 
local or general anesthesia from October 2009 to September 
2010. Patients were excluded if they had previous eyelid 
and/or lacrimal surgery, a lump overlying or involving the 
punctum and/or other parts of the tear drainage system, long 
complete upper lacrimal system obstruction (canaliculi and 
common canaliculus) on diagnostic probing, or nasolacrimal 
duct stenosis or obstruction on irrigation testing. The surgical 
options were explained, and informed consent was obtained. 
Patients were allocated a number in order of referral and were 
then randomly allocated into two groups.
self-retaining stent
The SRS consists of a silicon tube 25 mm, 30 mm, or 35 mm 
long and 0.64 mm wide, with an anchor-shaped head at each 
end to allow fixation. Each head consists of two flexible win-
glets that fold inwards during insertion through the punctum 
and spread back out after passage through the junction of the 
common canaliculus and lacrimal sac, thus securing stent 
fixation (Figure 1). A centrally placed marking on the tube 
acts as a reference point and allows verification of proper 
stent positioning following insertion. Insertion is performed 
in the office under slit-lamp. Both eyes can be intubated at the 
same time if necessary, and the stents remain in position for 
several weeks. The SRS is indicated for horizontal lacrimal 
duct obstruction and in particular for punctal stenosis. Other 
indications include punctal pathologies (ie, senile, post-
radiotherapy, post-chemotherapy, dermatological stenoses), 
canalicular pathologies (ie, infectious, traumatic), prevention 
of canalicular stenoses during radiotherapy and viral infec-
tions, and tearing as a result of permeable lacrimal ducts.
surgical procedure
SRS intubation was performed under topical anesthesia in 
the office under slit-lamp. Bicanalicular silicon intubation 
was performed in the operating room under either moni-
tored anesthesia or general anesthesia. Local anesthetic was 
administered around the lacrimal sac and intranasally around 
the inferior concha. Serially enlarging Bowman probes were 
inserted (ranging from number 00 to number 1) in the stenotic 
canaliculi to enlarge them prior to silicon intubation. Since 
the canaliculi were stenotic or short membranous and com-
pletely obstructed, the Bowman probes were passed through 
the strictured canaliculi without creation of a false passage. 
Bicanalicular Crawford tubes were inserted immediately 
after dilatation and passing of Bowman probes. Antibiotic 
and steroid eye drops were applied and the patients were 
instructed to continue them four times daily for one week. 
Postoperative follow-up examinations were performed at one 
week, one month, 3 months, and every 3 months thereafter. 
Tubes were left in place for a minimum of 3 months unless 
they became extruded.
Outcome measures
Epiphora was subjectively evaluated based upon patient 
satisfaction and clinical improvements by our grading scale, 
Figure 1 illustration showing components of the self-retaining bicanaliculus stent 




Bicanalicular srs versus silicon intubation
as follows: good improvement (free of epiphora), moderate 
improvement (strong improvement with occasional intermittent 
epiphora), or no improvement. Follow-up was   undertaken by 
an ophthalmologist blinded to the type of probing utilized. 
At each follow-up visit, epiphora was determined according 
to the patient’s grading scale, and the results were recorded 
in a database. Final clinical improvement was assessed at the 
end of follow-up and defined as successful, acceptable, or no 
improvement. All patients underwent probing with irrigation 
at their final visit.
Results
Thirty-eight eyes (38 canaliculi) from 38 patients (23 female, 
15 male) with canalicular obstruction and epiphora were 
randomized into two groups. Obstruction was partial 
in 25 patients and complete in 13. Twenty-one patients 
(14 partial obstruction, seven complete obstruction) were 
included in the SRS group and 17 patients (11 partial 
obstruction and six complete obstruction) in the bicanalicular 
silicon intubation group (Table 1). The underlying etiologies 
were unclear in 12 patients, while eight patients had a history 
of chemotherapy, nine had a history of infection, and nine 
had a history of an adverse reaction to local medication. The 
average patient age was 52.4 ± 7.5 (21–68) years.
The silicon tubes were left in place for on average 
3 ± 2.6 (3–6) months. Mean duration of follow-up after 
tube removal was 6.2 ± 1.1 (range 5–8) months. Immediate 
clinical outcome (at postoperative week 1) was successful in 
20 of 21 eyes (95.2%) in the SRS group and 15 of 17 eyes 
(88.2%) in the bicanalicular silicon intubation group. Final 
clinical evaluation was performed at the last visit. The clinical 
outcome was successful in 16 of 21 eyes in the SRS group 
(76.2%). More specifically, five (23.8%) and 11 (52.3%) 
eyes had successful and acceptable outcomes, respectively. 
The remaining five eyes had no improvement reported, and 
clinical examination revealed no punctal stenosis in these 
particular cases (see Table 1 for case details). In the bicanali-
cular silicon intubation group, the outcome was successful 
in 13 of 17 eyes (76.4%) at the final visit. In this group, 
the success rate was 90% and 50% for partial obstruction 
and complete obstruction, respectively. Four eyes had no 
improvement, comprising one eye with partial stenosis and 
three eyes with complete obstruction. Seven eyes (four in the 
SRS group and three in the bicanalicular silicon intubation 
group) had punctal stenosis, all of which were successfully 
intubated, and all of the patients had a satisfactory outcome 
(good or moderate improvement), with irrigation showing a 
patent duct. However, in patients with no improvement (five 
eyes in the SRS group and four eyes in the bicanalicular 
silicon intubation group), four eyes in each group showed 
obstructed canaliculi.
Discussion
The cause of acquired canalicular obstruction or stenosis is 
often not known, but is usually caused by an inflammatory 
condition (such as chronic blepharitis, dacryocystitis, infection 
[eg, herpes simplex, herpes zoster, infectious mononucleosis], 
trachoma, Stevens-Johnson syndrome, ocular cicatricial 
pemphigoid, lichen planus, or an idiopathic mucocutaneous 
inflammatory disease)1, trauma (laceration, chemical or 
thermal burn, dog bite), intrinsic canalicular tumors (eg, 
papilloma producing occlusion and secondary inflammation), 
irradiation for basal cell carcinoma, or as a side effect of 
medication (eg, echothiophate iodide, idoxuridine, topical 
cytotoxic drugs, antimetabolites, and chemotherapeutic 
regimens such as docetaxel and paclitaxel).1–3 Punctal or 
proximal canalicular stenosis has also been reported after 
spontaneous loss of a collared silicon punctal plug in dry eye 
patients; however, they usually remain asymptomatic with no 
further complications.4
There are multiple reasons for treatment of punctal and 
canalicular obstruction. Current recommendations involve 
identifying and potentially treating the underlying etiology 
in addition to intubation with a silicon tube to re-establish 
patency. Balloon canaliculoplasty has also been used to 
treat canalicular obstruction but, although initial success 
rates were impressive, long-term follow-up has shown high 
recurrence rates (with only 23%–43% patency in the long 
term), indicating the importance of concurrent silicon tube 
intubation of the lacrimal system.5,6 However, in a recent 
report by Zoumalan et al7, the final clinical outcomes after a 
mean of 6 months of follow-up were successful or   acceptable 
Table 1 Outcome of patients undergoing self-retaining bicanaliculus stent intubation or bicanalicular silicon intubation
SRS (n = 21) 14 partial, 7 complete BSI (n = 17) 11 partial, 6 complete P value
good 12 (10 partial, 2 complete) 7 (6 partial, 1 complete) 0.36
Moderate 4 (2 partial, 2 complete) 6 (4 partial, 2 complete) 0.33
no response 5 (2 partial, 3 complete) 4 (1 partial, 3 complete) 0.33
Abbreviations: srs, self-retaining bicanaliculus stent; Bsi, bicanalicular silicon intubation.Clinical Ophthalmology
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in 76.2% of patients with canalicular stenosis. However, 
it should be noted that this study contained patients with 
stenosis rather than obstruction.
Yang et al8 reported their experience with balloon canali-
culoplasty in conjunction with manual trephination and 
silicon tube intubation in patients with complete canalicular 
obstruction. They reported clinical improvement in 53.6% of 
patients with common canalicular obstruction and in 25.0% 
of those with monocanalicular obstruction after 12 months 
of follow-up. Khoubian et al9 reported on the efficacy of 
trephination and silicon stent intubation based on the level 
of obstruction in cases with complete canalicular obstruction. 
In their report, on average, 49% of eyes had complete relief 
of epiphora, 38% had partial relief, and 13% had no relief. 
Eighty percent of eyes with distal lower canalicular obstruc-
tion had complete relief and 20% had partial relief of epi-
phora. For eyes with distal bicanalicular obstruction, 66% 
had complete relief and 33% had partial relief. Patients with 
common canalicular obstructions had 59% complete, 29% 
partial, and 12% no relief. Proximal bicanalicular obstruc-
tions were the least successful, with 55% having partial relief 
and 45% having no relief.
In the present study, our success rate (defined as a good 
and moderate response) for both SRS and bicanalicular 
silicon intubation was 76%. However, when analysis was 
performed based on type of obstruction (partial or complete), 
the success rate for partial obstruction was 85% and 90% 
for SRS and bicanalicular silicon intubation, respectively. 
For complete obstruction, these values were 63% and 50% 
respectively. Our findings show that both options have good 
results in cases of partial obstruction, although the success 
rate is not as high in cases of complete obstruction, but 
they could be a satisfactory substitute for other surgical 
procedures, such as dacryocystorhinostomy or Jones tube 
implantation.
In summary, our study shows that SRS can effectively 
substitute for a more extensive procedure such as   bicanalicular 
silicon intubation in patients with canalicular obstruction, 
particularly in those with partial obstruction. The benefits of 
the newly developed SRS are that it is a simple procedure to 
perform, with easy implantation and extubation, low cost, and 
a lower rate of trauma compared with bicanalicular silicon 
intubation. In cases of complete obstruction, our success 
rate was not as high as in those with partial obstruction, but 
it would still be worthwhile to do these procedure even in 
these cases instead of a more extensive procedure, such as 
dacryocystorhinostomy accompanied by silicon intubation 
or Jones tube implantation.
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